Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Intraoperative Ultrasound Guidance With an Ultrasound-Visible Clip: A Practical and Cost-effective Option for Breast Cancer Localization.

Konen J, Murphy S, Berkman A, Ahern TP, Sowden M.

J Ultrasound Med. 2019 Nov 18. doi: 10.1002/jum.15172. [Epub ahead of print]

PMID:
31737930
2.

17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study.

Collin LJ, Ulrichsen SP, Ahern TP, Goodman M, McCullough LE, Waller LA, Bang Christensen K, Damkier P, Hamilton-Dutoit S, Lauridsen KL, Yacoub R, Christiansen PM, Ejlertsen B, Sørensen HT, Cronin-Fenton DP, Lash TL.

Acta Oncol. 2019 Oct 31:1-5. doi: 10.1080/0284186X.2019.1684560. [Epub ahead of print] No abstract available.

PMID:
31671023
3.

Posttraumatic Stress Disorder and Incident Infections: A Nationwide Cohort Study.

Jiang T, Farkas DK, Ahern TP, Lash TL, Sørensen HT, Gradus JL.

Epidemiology. 2019 Nov;30(6):911-917. doi: 10.1097/EDE.0000000000001071.

PMID:
31584893
4.

Phthalate exposure from drugs during pregnancy and possible risk of preterm birth and small for gestational age.

Broe A, Pottegård A, Hallas J, Ahern TP, Lamont RF, Damkier P.

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:293-299. doi: 10.1016/j.ejogrb.2019.07.023. Epub 2019 Jul 19.

PMID:
31400564
5.

Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II.

Lucht SA, Eliassen AH, Bertrand KA, Ahern TP, Borgquist S, Rosner B, Hankinson SE, Tamimi RM.

Cancer Causes Control. 2019 Sep;30(9):943-953. doi: 10.1007/s10552-019-01201-2. Epub 2019 Jul 1.

PMID:
31264139
6.

The Impact of an Acute Care Surgery Model on General Surgery Service Productivity.

Paine AN, Krompf BL, Borrazzo EC, Ahern TP, Malhotra AK, Norotsky MC, Tsai MH.

Perioper Care Oper Room Manag. 2018 Sep;12:26-30. doi: 10.1016/j.pcorm.2018.09.001. Epub 2018 Sep 24.

7.

Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.

Ahern TP, Broe A, Lash TL, Cronin-Fenton DP, Ulrichsen SP, Christiansen PM, Cole BF, Tamimi RM, Sørensen HT, Damkier P.

J Clin Oncol. 2019 Jul 20;37(21):1800-1809. doi: 10.1200/JCO.18.02202. Epub 2019 Apr 17.

PMID:
30995175
8.

Exposure to phthalate-containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case-control study.

Ennis ZN, Pottegård A, Ahern TP, Hallas J, Damkier P.

Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):528-535. doi: 10.1002/pds.4759. Epub 2019 Feb 22.

PMID:
30793813
9.

Towards a more precise and individualized assessment of breast cancer risk.

Wood ME, Farina NH, Ahern TP, Cuke ME, Stein JL, Stein GS, Lian JB.

Aging (Albany NY). 2019 Feb 20;11(4):1305-1316. doi: 10.18632/aging.101803.

10.

Postoperative opioid prescribing patterns and use after vascular surgery.

Colton IB, Fujii MH, Ahern TP, MacLean CD, Lahiri JE, Alef M, Stanley AC, Steinthorsson G, Bertges DJ.

Vasc Med. 2019 Feb;24(1):63-69. doi: 10.1177/1358863X18807540. Epub 2018 Nov 18.

PMID:
30449260
11.

Impact of Policy Interventions on Postoperative Opioid Prescribing.

MacLean CD, Fujii M, Ahern TP, Holoch P, Russell R, Hodges A, Moore J.

Pain Med. 2019 Jun 1;20(6):1212-1218. doi: 10.1093/pm/pny215.

PMID:
30412235
12.

Expression of survivin does not appear to influence breast cancer recurrence risk.

Collin LJ, Cronin-Fenton DP, Ahern TP, Christensen KB, Damkier P, Hamilton-Dutoit S, Kjaersgaard A, Lauridsen KL, Yacoub R, Christiansen P, Sørensen HT, Lash TL.

Acta Oncol. 2019 Feb;58(2):154-161. doi: 10.1080/0284186X.2018.1503419. Epub 2018 Oct 23.

PMID:
30351173
13.

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.

Collin LJ, Cronin-Fenton DP, Ahern TP, Christiansen PM, Damkier P, Ejlertsen B, Hamilton-Dutoit S, Kjærsgaard A, Silliman RA, Sørensen HT, Lash TL.

BMJ Open. 2018 Aug 1;8(7):e021805. doi: 10.1136/bmjopen-2018-021805.

14.

Statins: a role in breast cancer therapy?

Borgquist S, Bjarnadottir O, Kimbung S, Ahern TP.

J Intern Med. 2018 Oct;284(4):346-357. doi: 10.1111/joim.12806. Epub 2018 Jul 9. Review.

15.

Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.

Pottegård A, Lash TL, Cronin-Fenton D, Ahern TP, Damkier P.

Br J Clin Pharmacol. 2018 Sep;84(9):2152-2161. doi: 10.1111/bcp.13661. Epub 2018 Jul 8.

16.

Pharmacoepidemiology in Pharmacogenetics.

Ahern TP.

Adv Pharmacol. 2018;83:109-130. doi: 10.1016/bs.apha.2018.04.001. Epub 2018 May 10. Review.

PMID:
29801572
17.

Association of Statin Use With Overall and Cancer Survival.

Ahern TP, Borgquist S, Cronin-Fenton DP.

JAMA Oncol. 2018 Jul 1;4(7):1015-1016. doi: 10.1001/jamaoncol.2018.0733. No abstract available.

PMID:
29800042
18.

Re: Beta Blockers and Improved Progression-Free Survival in Patients With Advanced HER2 Negative Breast Cancer.

Sørensen GV, Cronin-Fenton DP, Sørensen HT, Damkier P, Ejlertsen B, Christiansen PM, Lash TL, Ahern TP.

Epidemiology. 2018 Sep;29(5):e39-e40. doi: 10.1097/EDE.0000000000000853. No abstract available.

PMID:
29771735
19.

Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide study.

Ennis ZN, Broe A, Pottegård A, Ahern TP, Hallas J, Damkier P.

Br J Clin Pharmacol. 2018 Aug;84(8):1798-1805. doi: 10.1111/bcp.13614. Epub 2018 Jun 3.

20.

Adjustment disorder and type-specific cancer incidence: a Danish cohort study.

Ahern TP, Veres K, Jiang T, Farkas DK, Lash TL, Sørensen HT, Gradus JL.

Acta Oncol. 2018 Oct;57(10):1367-1372. doi: 10.1080/0284186X.2018.1465586. Epub 2018 Apr 24.

21.

Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure.

Fujii MH, Hodges AC, Russell RL, Roensch K, Beynnon B, Ahern TP, Holoch P, Moore JS, Ames SE, MacLean CD.

J Am Coll Surg. 2018 Jun;226(6):1004-1012. doi: 10.1016/j.jamcollsurg.2018.01.058. Epub 2018 Feb 28.

22.

Association between use of phthalate-containing medication and semen quality among men in couples referred for assisted reproduction.

Broe A, Pottegård A, Hallas J, Ahern TP, Fedder J, Damkier P.

Hum Reprod. 2018 Mar 1;33(3):503-511. doi: 10.1093/humrep/dey009.

23.

Development of a predictive miRNA signature for breast cancer risk among high-risk women.

Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME.

Oncotarget. 2017 Nov 28;8(68):112170-112183. doi: 10.18632/oncotarget.22750. eCollection 2017 Dec 22.

24.

Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.

Cronin-Fenton D, Lash TL, Ahern TP, Damkier P, Christiansen P, Ejlertsen B, Sørensen HT.

Acta Oncol. 2018 Jan;57(1):120-128. doi: 10.1080/0284186X.2017.1407040. Epub 2017 Dec 5.

PMID:
29202630
25.

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

Damkier P, Kjærsgaard A, Barker KA, Cronin-Fenton D, Crawford A, Hellberg Y, Janssen EAM, Langefeld C, Ahern TP, Lash TL.

Sci Rep. 2017 Aug 10;7(1):7727. doi: 10.1038/s41598-017-08091-x.

26.

Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study.

Cronin-Fenton DP, Kjærsgaard A, Ahern TP, Mele M, Ewertz M, Hamilton-Dutoit S, Christiansen PM, Ejlertsen B, Sørensen HT, Lash TL, Silliman RA.

Acta Oncol. 2017 Sep;56(9):1155-1160. doi: 10.1080/0284186X.2017.1327720. Epub 2017 Jun 6.

PMID:
28585885
27.

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

Borgquist S, Giobbie-Hurder A, Ahern TP, Garber JE, Colleoni M, Láng I, Debled M, Ejlertsen B, von Moos R, Smith I, Coates AS, Goldhirsch A, Rabaglio M, Price KN, Gelber RD, Regan MM, Thürlimann B.

J Clin Oncol. 2017 Apr 10;35(11):1179-1188. doi: 10.1200/JCO.2016.70.3116. Epub 2017 Feb 13.

PMID:
28380313
28.

Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort.

Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Ahern TP, Thorlacius-Ussing O.

Am J Epidemiol. 2017 Sep 15;186(6):679-687. doi: 10.1093/aje/kww245.

PMID:
28338891
29.

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801. Epub 2017 Jan 17.

30.

Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.

Ahern TP, Hertz DL, Damkier P, Ejlertsen B, Hamilton-Dutoit SJ, Rae JM, Regan MM, Thompson AM, Lash TL, Cronin-Fenton DP.

Am J Epidemiol. 2017 Jan 15;185(2):75-85. doi: 10.1093/aje/kww178. Epub 2016 Dec 17. Review.

31.

Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.

Ahern TP, Beck AH, Rosner BA, Glass B, Frieling G, Collins LC, Tamimi RM.

J Clin Pathol. 2017 May;70(5):428-434. doi: 10.1136/jclinpath-2016-204107. Epub 2016 Oct 11.

32.

Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.

Ahern TP, Cronin-Fenton DP, Lash TL, Sørensen HT, Ording AG, Hamilton-Dutoit SJ, Hellberg Y.

Acta Oncol. 2016 Jun;55(6):734-41. doi: 10.3109/0284186X.2016.1150606. Epub 2016 Apr 8.

33.

Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT.

Epidemiology. 2016 Jul;27(4):586-93. doi: 10.1097/EDE.0000000000000480.

34.

Statin Use and Breast Cancer Risk in the Nurses' Health Study.

Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):201-6. doi: 10.1158/1055-9965.EPI-15-0654.

35.

Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort.

Ahern TP, Horváth-Puhó E, Spindler KL, Sørensen HT, Ording AG, Erichsen R.

Br J Cancer. 2016 Jan 12;114(1):96-102. doi: 10.1038/bjc.2015.406. Epub 2015 Dec 1.

36.

Opioids and breast cancer recurrence: A Danish population-based cohort study.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen PM, Ejlertsen B, Sjøgren P, Kehlet H, Sørensen HT.

Cancer. 2015 Oct 1;121(19):3507-14. doi: 10.1002/cncr.29532. Epub 2015 Jul 24.

37.

Statins and breast cancer prognosis: evidence and opportunities.

Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP.

Lancet Oncol. 2014 Sep;15(10):e461-8. doi: 10.1016/S1470-2045(14)70119-6. Review.

38.

Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.

Ahern TP, Tamimi RM, Rosner BA, Hankinson SE.

Breast Cancer Res Treat. 2014 Apr;144(2):427-35. doi: 10.1007/s10549-014-2886-x. Epub 2014 Feb 28.

39.

Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis.

Cronin-Fenton DP, Christensen M, Lash TL, Ahern TP, Pedersen L, Garne JP, Ewertz M, Autrup H, Sørensen HT, Hamilton-Dutoit S.

PLoS One. 2014 Jan 31;9(1):e87450. doi: 10.1371/journal.pone.0087450. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92620.

40.

Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer.

Ahern TP, Hankinson SE, Willett WC, Pollak MN, Eliassen AH, Tamimi RM.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1786-96. doi: 10.1158/1055-9965.EPI-13-0375.

41.

Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.

Sørensen GV, Ganz PA, Cole SW, Pedersen LA, Sørensen HT, Cronin-Fenton DP, Garne JP, Christiansen PM, Lash TL, Ahern TP.

J Clin Oncol. 2013 Jun 20;31(18):2265-72. doi: 10.1200/JCO.2012.43.9190. Epub 2013 May 6.

42.

Bias analysis to guide new data collection.

Lash TL, Ahern TP.

Int J Biostat. 2012 Jan 6;8(2). pii: /j/ijb.2012.8.issue-2/1557-4679.1345/1557-4679.1345.xml. doi: 10.2202/1557-4679.1345.

PMID:
22499734
43.

Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study.

Cronin-Fenton DP, Hellberg Y, Lauridsen KL, Ahern TP, Garne JP, Rosenberg C, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Acta Oncol. 2012 Feb;51(2):254-61. doi: 10.3109/0284186X.2011.633556. Epub 2011 Nov 30.

44.

The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable.

Ahern TP, Pedersen L, Sværke C, Rothman KJ, Sørensen HT, Lash TL.

Am J Epidemiol. 2011 Dec 15;174(12):1382-90. doi: 10.1093/aje/kwr268. Epub 2011 Nov 1.

45.

Re: Use of archived specimens in evaluation of prognostic and predictive biomarkers.

Ahern TP, Hankinson SE.

J Natl Cancer Inst. 2011 Oct 19;103(20):1558-9; author reply 1559-60. doi: 10.1093/jnci/djr327. Epub 2011 Sep 13. No abstract available.

PMID:
21917608
46.

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.

J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. doi: 10.1093/jnci/djr291. Epub 2011 Aug 2.

47.

Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43. doi: 10.1158/1055-9965.EPI-11-0419. Epub 2011 Jul 12.

48.

CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Garne JP, Sørensen HT, Hellberg Y, Christensen M, Pedersen L, Hamilton-Dutoit S.

J Natl Cancer Inst. 2011 Mar 16;103(6):489-500. doi: 10.1093/jnci/djr010. Epub 2011 Feb 15.

49.

Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Rosenberg CL, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Clin Epidemiol. 2010 Oct 22;2:241-6. doi: 10.2147/CLEP.S13811.

50.

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, Silliman RA, Hamilton-Dutoit S, Garne JP, Ewertz M, Sørensen HT, Pedersen L.

Acta Oncol. 2010 Apr;49(3):305-12. doi: 10.3109/02841860903575273.

Supplemental Content

Loading ...
Support Center